Wegovy weight loss before and after pictures: what the results really look like

Why individual before and after photos can mislead you

Before and after wegovy pictures are everywhere online. Some are genuine; many are not. Even the real ones are a selective sample, the people who post dramatic transformations are self-selected, which means the average result you see scrolling through social media is almost certainly better than the actual average in clinical practice. Photography angle, lighting, posture, clothing and the length of the 'after' window all shape what you see. Two people with identical starting BMIs and identical doses can look completely different at six months.

That is not a reason to dismiss the evidence. It is a reason to go to the evidence directly. The STEP 1 trial, published in the New England Journal of Medicine, randomised 1,961 adults with obesity and followed them for 68 weeks. Participants using semaglutide 2.4mg alongside lifestyle support lost an average of around 15% of their body weight. For someone starting at 100kg, that is 15kg. Visible. Substantial. And also an average, some lost more, some less. The data does not tell you where you will land, but it tells you where most people end up. That is a more reliable frame than before and after wegovy pictures chosen for their drama.

If you are curious about what results tend to look like specifically in the first few weeks, the one-month picture is worth understanding on its own terms, early on, the lower starter doses are doing adjustment work, not heavy lifting.

What shapes your personal result

The clinical average is a starting point, not a ceiling or a floor. Several factors push results in either direction.

Dose reached matters enormously. The 2.4mg figure in STEP 1 is a maintenance dose that takes roughly 16 to 20 weeks to reach, stepping up from 0.25mg. Not everyone tolerates the full escalation, some people stabilise at a lower dose, and their results will differ accordingly. The newer 7.2mg single-dose pen, approved by the MHRA in April 2026, showed average losses of around 20.7% in trials, narrowing the gap with tirzepatide significantly. Our Wegovy overview covers what the dose options mean in practice.

Lifestyle engagement is the other big lever. The trials paired semaglutide with a reduced-calorie diet and increased physical activity. People who maintained that alongside the medicine consistently did better than those who relied on the medicine alone. Protein intake, hydration and strength-based activity all feature in what our prescribers discuss with patients at review.

Starting weight also plays a role. Someone with a BMI of 45 losing 15% will lose more kilograms in absolute terms than someone at BMI 31, but the percentage reduction and the health gains are comparable. For a fuller breakdown of how long meaningful change typically takes, this page on Wegovy timelines walks through what to expect month by month.

Side effects during titration can slow progress temporarily. Nausea, reduced appetite and changes in digestion are common in the first weeks after a dose increase. For context on how digestion changes on the medicine, gastric emptying and Wegovy is worth reading. These effects usually settle, and most people find appetite suppression then becomes the dominant experience.

First-month results and the slower start that puts people off

A lot of the before and after wegovy pictures that circulate online show dramatic six-month or twelve-month transformations. The first month looks nothing like that. The 0.25mg starting dose is a tolerability dose, its job is to let your body adjust, not to drive weight loss. Most people lose relatively little in weeks one to four, which can feel discouraging if you were expecting visible change immediately.

The first-month Wegovy results page goes into this in detail, but the short version is: patience in month one pays off in months three to six. By the three-month mark, most people are on 1mg or 1.7mg, appetite suppression is established, and loss tends to accelerate. The three-month picture is typically where the change starts to feel real.

Worth noting: if you are starting in December or planning around a holiday, the first few weeks of adjustment are often easier when life is relatively settled. Dose increases on top of disrupted eating patterns can amplify nausea. Many people find Monday starts or post-payday orders help them build a routine from day one.

Semaglutide results more broadly, and what changes when the setting does

Semaglutide before and after pictures sometimes come from Ozempic users rather than Wegovy users. The active molecule is the same, but Ozempic is licensed for type 2 diabetes, not weight management, and its doses top out lower. Results reported informally by people using Ozempic off-label for weight loss are not a reliable proxy for what Wegovy at full therapeutic dose achieves. The semaglutide and Ozempic comparison page sets this out clearly.

There is also a growing body of images tagged as semaglutide B12 combinations. These are not a licensed product in the UK. B12 is sometimes added by compounders, not by Novo Nordisk, and the B12 combination page covers what that distinction means for the results you should expect.

For female-specific results and how body composition changes tend to present differently, the female results page draws together the relevant trial sub-group data. Cost is a practical factor too, the Wegovy price page explains what private treatment involves and what a legitimate price should include. If you want to see the full range of treatment options available through our pharmacy, the treatment overview is the place to start. And if you have questions not covered here, our FAQs cover the most common ones. When you are ready to check whether you are eligible, a free consultation with one of our prescribers is the next step.